Isolated nucleic acid molecules coding for tumor rejection antig

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 691, 435325, 4353201, 4352523, 536 235, 530350, C12N 500, C07H 2104, C07K 1400

Patent

active

058307532

ABSTRACT:
A new family of tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as DAGE tumor rejection antigen precursors, and the nucleic acid molecules which code for them are referred to as GAGE coding molecules. Various diagnostic and therapeutic uses of the coding sequences and the tumor rejection antigens, and their precursor molecules are described.

REFERENCES:
patent: 5342774 (1994-08-01), Boon et al.
Coulie et al, "A New Gene Coding For A Differentiation Antigen Recognized By Autologous Cytolytic T Lymphocytes", J. Exp. Med. 180: 35-42 (Jul. 1994).
Engelhardt, "Structure of Peptides Associated With Class I And Class II Molecules", Ann. Rev. Immunol 12: 181-207 (1994).
Falk et al, "Allele specific peptide ligand motifs of HLA-C-molecules", Proc. Natl. Acad. Sci. USA 90: 12005-12009 (Dec. 1993).
Zemmour et al, "HLA Class I nucleotide sequences, 1992", -Immunogenetics 37: 239-259 (1993).
Rupert et al, "Prominent Role of Secondary Anchor Residues In-Peptide Binding to HLA-A2.1 Molecules", Cell 74: 929-937 (Sep. 10, 1993).
Traversari et al, "A Nonapeptide Encoded by Human Gene MAGE-1 Is-Recognized on HLA-A1 By Cytolytic T Lymphocytes, Directed Against Tumor Antigrn MZ2-E", J. Exp. Med. 176: 1453-1457 (Nov. 1992).
Van der Bruggen et al, "A Gene Encoding An Antigen Recognized-By Cytolytic T Lymphocytes on a Human Melanoma", Science 254: 1643-1647 (1991).
Rotzschke, et al "Isolated and analysis of naturally processed-viral peptides as recognized by cytolytic T cells", Nature 348: 252-254 (Nov. 15, 199).
Bjorkman et al, "The foreign antigen binding site and T cell-recognition of Class I histocompatibility antigens", Nature 329: 512-518 (Oct. 8, 1987).
Robbins, P.F. et al. 1994. Cancer Research, 54: 3124-3126.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Isolated nucleic acid molecules coding for tumor rejection antig does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isolated nucleic acid molecules coding for tumor rejection antig, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated nucleic acid molecules coding for tumor rejection antig will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-688487

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.